Ignite Creation Date:
2024-05-05 @ 10:43 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01178073
Status:
COMPLETED
Last Update Posted:
2017-09-13
First Post:
2010-07-15
Brief Title:
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension PAH
Sponsor:
Organization:
GlaxoSmithKline